GRPH insider transactions
Graphite Bio Inc. (GRPH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for GRPH
- Mccollum James W bought $501,093 worth of shares (31,332 units at $15.99) (SEC Form 4)4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- New insider Alpha Wave Ventures Gp, Ltd claimed ownership of 3,612,211 shares (SEC Form 3)3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- Ra Capital Management, L.P. was granted 3,245,785 shares, bought $14,023,561 worth of shares (933,038 units at $15.03) and bought $976,514 worth of Common Stockj (64,971 units at $15.03) (SEC Form 4)4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Ra Capital Management, L.P.3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Thunen Shelley B4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- Mccollum James W was granted 589,267 shares (SEC Form 4)4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Guerard Frederic4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Scheiner Zachary4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Drapkin Kimberlee C4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Scheiner Zachary3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by George Jeffrey P.4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Chevallard Daniel R.4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Olsson Shawn4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- Odrich Marc was granted 99,599 shares (SEC Form 4)4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Schimmelpennink Evert B.4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Thunen Shelley B3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Mccollum James W3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Guerard Frederic3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider George Jeffrey P.3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Chevallard Daniel R.3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Olsson Shawn3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Odrich Marc3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Schimmelpennink Evert B.3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- Versant Venture Capital Vi, L.P. acquired 598,203 shares (SEC Form 4)4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- New insider Versant Venture Capital Vii, L.P. claimed ownership of 1,598,789 shares (SEC Form 3)3 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Drapkin Kimberlee C4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Drapkin Kimberlee C3 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Viney Joanne L.4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Porteus Matthew4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Karsen Perry A4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Jimenez Joseph4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Jerel Davis4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Carlo Rizzuto4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Bassan Abraham4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Shah Smital4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Hege Kristen4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Young Alethia4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Lehrer-Graiwer Joshua4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 3: New insider Ecor1 Capital, Llc claimed ownership of 8,538,446 shares3 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Viney Joanne L.4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Porteus Matthew4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Karsen Perry A4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Jimenez Joseph4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Jerel Davis4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Carlo Rizzuto4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Bassan Abraham4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Shah Smital4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Hege Kristen4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4: Samsara Biocapital, L.P. bought $1,731,068 worth of shares (424,464 units at $4.08)4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4: Gutry Phil bought $20,050 worth of shares (5,000 units at $4.01), increasing direct ownership by 2% to 299,941 units4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Young Alethia4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 3 filed by new insider Young Alethia3 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Lehrer-Graiwer Joshua4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4 filed by Gutry Phil4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4: Samsara Biocapital, L.P. bought $1,099,100 worth of shares (123,000 units at $8.94)4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4: Samsara Biocapital, L.P. bought $888,677 worth of shares (97,670 units at $9.10)4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4: Samsara Biocapital, L.P. bought $227,533 worth of shares (22,329 units at $10.19)4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4: Samsara Biocapital, L.P. bought $2,047,103 worth of shares (201,685 units at $10.15)4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4: Samsara Biocapital, L.P. bought $667,665 worth of shares (50,800 units at $13.14)4 - Graphite Bio, Inc. (0001815776) (Issuer)
- SEC Form 4: Samsara Biocapital, L.P. bought $1,968,973 worth of shares (145,496 units at $13.53)4 - Graphite Bio, Inc. (0001815776) (Issuer)